Characterization of Tau in Cerebrospinal Fluid Using Mass Spectrometry

The neurodegenerative disorder Alzheimer’s disease (AD) is the most common cause of dementia in the elderly. The presence of neurofibrillary tangles, consisting of hyperphosphorylated tau protein, is one of the major neuropathologic characteristics of the disease, making this protein an attractive b...

Full description

Saved in:
Bibliographic Details
Published inJournal of proteome research Vol. 7; no. 5; pp. 2114 - 2120
Main Authors Portelius, Erik, Hansson, Sara F, Tran, Ai Jun, Zetterberg, Henrik, Grognet, Pierre, Vanmechelen, Eugeen, Höglund, Kina, Brinkmalm, Gunnar, Westman-Brinkmalm, Ann, Nordhoff, Eckhard, Blennow, Kaj, Gobom, Johan
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 01.05.2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The neurodegenerative disorder Alzheimer’s disease (AD) is the most common cause of dementia in the elderly. The presence of neurofibrillary tangles, consisting of hyperphosphorylated tau protein, is one of the major neuropathologic characteristics of the disease, making this protein an attractive biomarker for AD and a possible target for therapy. Here, we describe an optimized immunoprecipitation mass spectrometry method that enables, for the first time, detailed characterization of tau in human cerebrospinal fluid. The identities of putative tau fragments were confirmed using nanoflow liquid chromatography and tandem mass spectrometry. Nineteen tryptic fragments of tau were detected, of which 16 are found in all tau isoforms while 3 represented unique tau isoforms. These results pave the way for clinical CSF studies on the tauopathies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1535-3893
1535-3907
DOI:10.1021/pr7008669